[Skip to Content]
[Skip to Content Landing]
Article
November 1950

FAILURE OF AUREOMYCIN HYDROCHLORIDE THERAPY IN WARTS

Author Affiliations

Medical Director, Pittsburgh Skin and Cancer Foundation PITTSBURGH; Medical Director, Lederle Laboratories Division, American Cyanamid Company PEARL RIVER, N. Y.

AMA Arch Derm Syphilol. 1950;62(5):714-715. doi:10.1001/archderm.1950.01530180103028
Abstract

After observation of an almost specific-like response of the condition of a 1 year old child, who presented multiple molluscum contagiosum lesions over the diaper-covered area, to treatment with aureomycin, just as originally reported by Guy and associates,1 and following the suggestion of these authors that the virucidal activity of this same antibiotic be explored in the treatment of ordinary warts, we undertook such evaluation in 10 patients.

The unreliability and the vagary in the behavior of warts under any kind of treatment was again demonstrated in this small series, as the first and the second patients were seemingly cured as a direct result of the ingestion of aureomycin hydrochloride, while the other eight, though on exactly the same treatment, showed absolutely no response.

Each patient in this series had treatment-resistant warts, as all had had one or more accepted forms of treatment previously. In none was the condition

×